Bicocca Open Archive

Logo unimib boa
INVERNIZZI, PIETRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.075
EU - Europa 10.298
AS - Asia 5.413
SA - Sud America 450
AF - Africa 62
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 14
Totale 35.326
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.846
IT - Italia 2.565
SG - Singapore 2.248
RU - Federazione Russa 1.855
DE - Germania 1.414
SE - Svezia 1.339
IE - Irlanda 1.258
CN - Cina 1.255
HK - Hong Kong 1.130
GB - Regno Unito 529
BR - Brasile 392
UA - Ucraina 304
AT - Austria 302
CA - Canada 206
ID - Indonesia 187
FR - Francia 164
VN - Vietnam 162
FI - Finlandia 153
NL - Olanda 119
TR - Turchia 112
IN - India 93
DK - Danimarca 83
BE - Belgio 42
JP - Giappone 33
MY - Malesia 23
CZ - Repubblica Ceca 20
PT - Portogallo 20
ES - Italia 19
IR - Iran 19
ZA - Sudafrica 19
AR - Argentina 18
CH - Svizzera 17
PK - Pakistan 17
PL - Polonia 16
TW - Taiwan 16
IL - Israele 15
RO - Romania 15
KR - Corea 14
PH - Filippine 14
GR - Grecia 13
IQ - Iraq 11
AU - Australia 10
LT - Lituania 10
SK - Slovacchia (Repubblica Slovacca) 10
EC - Ecuador 9
MA - Marocco 8
UZ - Uzbekistan 8
A2 - ???statistics.table.value.countryCode.A2??? 7
BD - Bangladesh 7
DZ - Algeria 7
MX - Messico 7
NO - Norvegia 7
AE - Emirati Arabi Uniti 6
EU - Europa 6
PY - Paraguay 6
RS - Serbia 6
SA - Arabia Saudita 6
SC - Seychelles 6
AZ - Azerbaigian 5
CL - Cile 5
CO - Colombia 5
EG - Egitto 5
JM - Giamaica 5
VE - Venezuela 5
AL - Albania 4
BO - Bolivia 4
GH - Ghana 4
MM - Myanmar 4
NZ - Nuova Zelanda 4
PA - Panama 4
PE - Perù 4
CR - Costa Rica 3
HU - Ungheria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
MU - Mauritius 3
TH - Thailandia 3
BG - Bulgaria 2
CM - Camerun 2
GE - Georgia 2
JO - Giordania 2
LI - Liechtenstein 2
LK - Sri Lanka 2
LU - Lussemburgo 2
UY - Uruguay 2
ZW - Zimbabwe 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KE - Kenya 1
Totale 35.313
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.833
Fairfield 1.778
Singapore 1.516
Woodbridge 1.345
Dublin 1.207
Chandler 1.143
Hong Kong 1.112
Ashburn 1.067
Wilmington 1.023
Houston 977
Frankfurt am Main 951
Milan 789
Seattle 760
Cambridge 615
New York 562
Dearborn 501
Santa Clara 480
Princeton 468
Jacksonville 371
Chicago 262
Vienna 259
Lawrence 229
Altamura 213
Nanjing 209
London 207
Jakarta 179
Shanghai 178
San Diego 136
Beijing 134
Rome 120
Boardman 109
Moscow 92
Nuremberg 87
Los Angeles 79
Dong Ket 78
Council Bluffs 71
Helsinki 70
Andover 67
Guangzhou 67
Lachine 62
Toronto 60
Florence 56
Hangzhou 55
Nanchang 51
Ottawa 45
Monza 42
Hebei 41
Brussels 40
Shenyang 38
Changsha 37
Falls Church 37
São Paulo 37
Bari 36
Norwalk 36
Jinan 35
Bologna 33
Fremont 33
Lissone 31
Munich 31
Pune 31
Jiaxing 28
Tianjin 28
Washington 27
Turin 25
San Mateo 23
Dallas 22
Kunming 22
Mountain View 21
Zhengzhou 21
Padova 19
Edmonton 18
Lappeenranta 18
Leawood 17
Taizhou 17
Belo Horizonte 16
Brno 16
Düsseldorf 16
Kilburn 16
Ningbo 16
Penang 16
Genoa 15
Naples 15
Rio de Janeiro 14
Bergamo 13
Desio 13
Hefei 13
Lisbon 13
Amsterdam 12
Groningen 12
Mumbai 12
Paris 12
Redmond 12
Seregno 12
Buffalo 11
Garbagnate Milanese 11
Kiev 11
Kocaeli 11
Lauterbourg 11
Tappahannock 11
Tokyo 11
Totale 24.858
Salva come PNG Salva come JPEG
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 439
Validation of the Italian version of fisk fatigue severity score (FFSS) and PBC-40 373
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 365
Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model 352
A worldwide cross-ethnic study of quality of life in patients with PBC: Attitude or latitude? 315
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 265
A short version of a HRQol questionnaire for Italian and Japanese patients with PBC 261
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 258
Knockout of α-calcitonin gene-related peptide attenuates cholestatic liver injury by differentially regulating cellular senescence of hepatic stellate cells and cholangiocytes 256
Amelioration of Ductular Reaction by Stem Cell Derived Extracellular Vesicles in MDR2 Knockout Mice via Lethal-7 microRNA 244
Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma 235
Exploring the landscape of steatotic liver disease in the general US population 232
Better end points needed in primary sclerosing cholangitis trials 228
Hepatic focal nodular hyperplasia after pediatric hematopoietic stem cell transplantation: The impact of hormonal replacement therapy and iron overload 227
Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis 223
New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma 218
Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms 217
A second update on mapping the human genetic architecture of COVID-19 215
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 215
The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective 213
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 206
Dermatological Complications After Solid Organ Transplantation 205
FRI-006-Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 204
Mapping the human genetic architecture of COVID-19 202
Understanding short bowel syndrome: Current status and future perspectives 200
Precision medicine in primary biliary cholangitis 199
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 198
Risk stratification in primary sclerosing cholangitis 198
Female preponderance of primary biliary cholangitis is all about our understanding of its autoimmune nature 197
It's as if PBC didn’t exist: The illness experience of women affected by primary biliary cirrhosis 196
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 196
Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells 195
Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy 194
The X-factor in primary biliary cirrhosis: Monosomy X and xenobiotics 192
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 191
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 191
Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland 190
From pathogenesis to novel therapies in the treatment of primary biliary cholangitis 189
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 189
AISF position paper on liver disease and pregnancy 187
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 187
Endocrinology and Metabolic Diseases (Including Diabetes) 186
Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development 186
High rates of 30-day mortality in patients with cirrhosis and COVID-19 185
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 184
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 184
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach 182
miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation 182
Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth 180
Neuropeptide Y inhibits cholangiocarcinoma cell growth and invasion 179
Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growth 179
The Seat of Life. What a Lesson from the Stigmatized Saints 178
New Therapeutic Targets in Autoimmune Cholangiopathies 177
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 176
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 176
Increased local dopamine secretion has growth-promoting effects in cholangiocarcinoma 176
Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis 176
The challenges of primary biliary cholangitis: What is new and what needs to be done 176
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 174
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 174
Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers 173
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 173
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 173
A National Hospital‐Based Study of Hospitalized Patients With Primary Biliary Cholangitis 171
Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis 171
Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature 171
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 170
Y chromosome loss in male patients with primary biliary cirrhosis 170
“I Miss My Liver.” Nonmedical Sources in the History of Hepatocentrism 169
Novel insights in primary biliary cholangitis (PBC) epidemiology using administrative records 169
Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism 166
Validation of the Japanese version of the Fisk Fatigue Severity Score (FFSS) in Japanese patients with primary biliary cirrhosis 165
MicroRNAs in autoimmunity and inflammatory bowel disease: Crucial regulators in immune response 164
Nicotine Promotes Cholangiocarcinoma Growth in Xenograft Mice 163
Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis 163
The Fingerprint of Antimitochondrial Antibodies and the Etiology of Primary Biliary Cholangitis 161
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 161
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 160
Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma; its synthesis is reduced favoring cholangiocarcinoma growth 160
Immune-mediated drug-induced liver injury: Immunogenetics and experimental models 160
Autoimmune liver diseases 159
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study 159
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 159
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 158
Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease 155
Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma 154
Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2−/− mice 153
Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis 152
Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation 152
Expert clinical management of autoimmune hepatitis in the real world 151
Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases 149
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: A multicentre international study 149
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 148
Reply to: “A spotlight on natural killer cells in primary biliary cholangitis” 147
The mode of dexamethasone decoration influences avidin-nucleic-acid-nano-assembly organ biodistribution and in vivo drug persistence 147
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 146
Relationship between illness perception, anxiety, depression and fatigue in HCV patients 145
A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis 145
Genetics and epigenetics of primary biliary cirrhosis 145
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controls 144
Totale 19.217
Salva come PNG Salva come JPEG
Categoria #
all - tutte 156.581
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.581
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.022 0 0 0 0 0 0 0 0 0 597 280 145
2020/20216.102 238 294 750 490 466 640 725 751 472 458 389 429
2021/20223.372 349 274 450 243 204 240 132 212 147 214 312 595
2022/20235.371 601 1.340 437 474 462 807 153 297 443 94 150 113
2023/20244.867 131 159 172 426 549 1.098 753 188 362 248 86 695
2024/20258.670 792 1.268 738 608 973 478 672 489 1.171 1.481 0 0
Totale 37.016